Langenbeck's Archives of Surgery

, Volume 400, Issue 8, pp 907–927 | Cite as

Surgical management of secondary hyperparathyroidism in chronic kidney disease—a consensus report of the European Society of Endocrine Surgeons

  • Kerstin Lorenz
  • Detlef K. Bartsch
  • Juan J. Sancho
  • Sebastien Guigard
  • Frederic Triponez



Despite advances in the medical management of secondary hyperparathyroidism due to chronic renal failure and dialysis (renal hyperparathyroidism), parathyroid surgery remains an important treatment option in the spectrum of the disease. Patients with severe and complicated renal hyperparathyroidism (HPT), refractory or intolerant to medical therapy and patients with specific requirements in prospect of or excluded from renal transplantation may require parathyroidectomy for renal hyperparathyroidism.


Present standard and actual controversial issues regarding surgical treatment of patients with hyperparathyroidism due to chronic renal failure were identified, and pertinent literature was searched and reviewed. Whenever applicable, evaluation of the level of evidence concerning diagnosis and management of renal hyperparathyroidism according to standard criteria and recommendation grading were employed. Results were discussed at the 6th Workshop of the European Society of Endocrine Surgeons entitled Hyperparathyroidism due to multiple gland disease: An evidence-based perspective.


Presently, literature reveals scant data, especially, no prospective randomized studies to provide sufficient levels of evidence to substantiate recommendations for surgery in renal hyperparathyroidism. Appropriate surgical management of renal hyperparathyroidism involves standard bilateral exploration with bilateral cervical thymectomy and a spectrum of four standardized types of parathyroid resection that reveal comparable outcome results with regard to levels of evidence and recommendation. Specific patient requirements may favour one over the other procedure according to individualized demands.


Surgery for patients with renal hyperparathyroidism in the era of calcimimetics continues to play an important role in selected patients and achieves efficient control of hyperparathyroidism. The overall success rate and long-term control of renal hyperparathyroidism and optimal handling of postoperative metabolic effects also depend on the timely indication, individually suitable type of parathyroid resection and specialized endocrine surgery.


Renal hyperparathyroidism Tertiary hyperparathyroidism Parathyroidectomy Thymectomy Cinacalcet IOPTH 


Compliance with ethical standards

This article does not contain any studies with human participants or animals performed by any of the authors.

Conflicts of interest



  1. 1.
    Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH et al (2015) Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: The DOPPS Study. Clin J Am Soc Nephrol 10(1):98–109PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Ishani A, Liu J, Wetmore JB, Lowe KA, Do T, Bradbury BD et al (2015) Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. Clin J Am Soc Nephrol 10(1):90–97PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Sackett DL. Evidence-based medicine. Wiley; 2000.Google Scholar
  4. 4.
    Heinrich S, Schäfer M, Rousson V, Clavien P-A (2006) Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 243(2):154PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Pitt SC, Sippel RS, Chen H (2009) Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am 89(5):1227–1239PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 113:S1Google Scholar
  7. 7.
    Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kid Dis 42(S1)Google Scholar
  8. 8.
    Tominaga Y, Matsuoka S, Sato T (2005) Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial 9(1):44–47PubMedCrossRefGoogle Scholar
  9. 9.
    Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15(8):2208–2218PubMedCrossRefGoogle Scholar
  10. 10.
    Eknoyan G, Levin NW (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266Google Scholar
  11. 11.
    Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements 3(1):1–150CrossRefGoogle Scholar
  12. 12.
    Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T et al (2005) Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 67(3):1179–1187PubMedCrossRefGoogle Scholar
  13. 13.
    Matsuoka S, Tominaga Y, Sato T, Uno N, Hiramitu T, Goto N et al (2008) Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism. Ther Apher Dial 12(5):391–395PubMedCrossRefGoogle Scholar
  14. 14.
    Chroustova D, Kubinyi J, Trnka J, Adamek S (2014) The role of 99mTc-MIBI SPECT/low dose CT with 3D subtraction in patients with secondary hyperparathyroidism due to chronic kidney disease. Endocr Regul 48(2):55–63PubMedCrossRefGoogle Scholar
  15. 15.
    Michaud L, Burgess A, Huchet V, Lefevre M, Tassart M, Ohnona J et al (2014) Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab 99(12):4531–4536PubMedCrossRefGoogle Scholar
  16. 16.
    Alkhalili E, Tasci Y, Aksoy E, Aliyev S, Soundararajan S, Taskin E et al (2015) The utility of neck ultrasound and sestamibi scans in patients with secondary and tertiary hyperparathyroidism. World J Surg 39(3):701–705PubMedCrossRefGoogle Scholar
  17. 17.
    Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG et al (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350(15):1516–1525PubMedCrossRefGoogle Scholar
  18. 18.
    Vervloet M, du Buf-Vereijken P, van Loon BP, Manamley N, Reichert L, Gregoor PS (2013) Cinacalcet for secondary hyperparathyroidism: from improved mineral levels to improved mortality? Neth J Med 71(7):348–354PubMedGoogle Scholar
  19. 19.
    Moe SM, Cunningham J, Bommer J, Adler S, Rosansky SJ, Urena-Torres P et al (2005) Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrol Dial Transplant 20(10):2186–2193PubMedCrossRefGoogle Scholar
  20. 20.
    Raggi P, Chertow GM, Torres PU, Csiky B, Naso A, Nossuli K et al (2011) The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 26(4):1327–1339PubMedCrossRefGoogle Scholar
  21. 21.
    Ketteler M, Martin KJ, Wolf M, Amdahl M, Cozzolino M, Goldsmith D et al (2012) Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study. Nephrol Dial Transplant 27(8):3270–3278PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Goldsmith D, Covic A, Vervloet M, Cozzolino M, Nistor I, Chronic Kidney Disease-Mineral Bone Disease Working Group et al (2015) Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement. Nephrol Dial Transplant 30(5):698–700PubMedCrossRefGoogle Scholar
  23. 23.
    Moe SM, Chertow GM, Coburn JW, Quarles LD, Goodman WG, Block GA et al (2005) Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 67(2):760–771PubMedCrossRefGoogle Scholar
  24. 24.
    Prieto FT, Blanco GB, Garcia MN, Chaves VC, GarcíaJiménez R, Palomo PP et al (2009) Calcimimetics and bone mineral density in renal transplant patients with persistent secondary hyperparathyroidism. Transplant Proc 41(6):2144–2147CrossRefGoogle Scholar
  25. 25.
    Weber KJ, Misra S, Lee JK, Wilhelm SW, DeCresce R, Prinz RA (2004) Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery 136(6):1154–1159PubMedCrossRefGoogle Scholar
  26. 26.
    Tominaga Y, Matsuoka S, Uno N, Sato T (2008) Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics. Ther Apher Dial 12(s1):S21–S26PubMedCrossRefGoogle Scholar
  27. 27.
    Kovacevic B, Ignjatovic M, Zivaljevic V, Cuk V, Scepanovic M, Petrovic Z et al (2012) Parathyroidectomy for the attainment of NKF-K/DOQI and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism. Langenbecks Arch Surg 397(3):413–420PubMedCrossRefGoogle Scholar
  28. 28.
    Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM et al (2008) Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients. Nephrol Dial Transplant 23(7):2319–2323PubMedCrossRefGoogle Scholar
  29. 29.
    Stanbury S, Lumb G, Nicholson W (1960) Elective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet 275(7128):793–798CrossRefGoogle Scholar
  30. 30.
    Madorin C, Owen RP, Fraser WD, Pellitteri PK, Radbill B, Rinaldo A et al (2012) The surgical management of renal hyperparathyroidism. Eur Arch Otorhinolaryngol 269(6):1565–1576PubMedCrossRefGoogle Scholar
  31. 31.
    Schneider R, Bartsch DK (2015) Role of surgery in the treatment of renal secondary hyperparathyroidism. Br J Surg 102(4):289–290PubMedCrossRefGoogle Scholar
  32. 32.
    Gasparri G, Camandona M, Abbona GC, Papotti M, Jeantet A, Radice E et al (2001) Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg 233(1):65PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Tominaga Y, Katayama A, Sato T, Matsuoka S, Goto N, Haba T et al (2003) Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant 18(3):iii65–iii70PubMedGoogle Scholar
  34. 34.
    Triponez F, Kebebew E, Dosseh D, Duh QY, Hazzan M, Noel C et al (2006) Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. Surgery 140(6):990–997, Discussion 7–9 PubMedCrossRefGoogle Scholar
  35. 35.
    Wagner PK, Seesko HG, Rothmund M (1991) Replantation of cryopreserved human parathyroid tissue. World J Surg 15(6):751–755PubMedCrossRefGoogle Scholar
  36. 36.
    Wells SA Jr, Ellis GJ, Gunnells JC, Schneider AB, Sherwood LM (1976) Parathyroid autotransplantation in primary parathyroid hyperplasia. N Engl J Med 295(2):57–62PubMedCrossRefGoogle Scholar
  37. 37.
    Casanova D, Sarfati E, De Francisco A, Amado JA, Arias M, Dubost C (1991) Secondary hyperparathyroidism: diagnosis of site of recurrence. World J Surg 15(4):546–549, discussion 9–50 PubMedCrossRefGoogle Scholar
  38. 38.
    Schlosser K, Sitter H, Rothmund M, Zielke A (2004) Assessing the site of recurrence in patients with secondary hyperparathyroidism by a simplified Casanova autograftectomy test. World J Surg 28(6):583–588PubMedCrossRefGoogle Scholar
  39. 39.
    Rothmund M, Wagner PK, Schark C (1991) Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 15(6):745–750PubMedCrossRefGoogle Scholar
  40. 40.
    Richards ML, Wormuth J, Bingener J, Sirinek K (2006) Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management? Surgery 139(2):174–180PubMedCrossRefGoogle Scholar
  41. 41.
    Lorenz K, Sekulla C, Dralle H (2013) Chirurgisches Management des renalen Hyperparathyreoidismus. Zentralbl Chir 138(Suppl 2):e47–e54PubMedGoogle Scholar
  42. 42.
    Schneider R, Bartsch DK, Schlosser K (2013) Relevance of bilateral cervical thymectomy in patients with renal hyperparathyroidism: analysis of 161 patients undergoing reoperative parathyroidectomy. World J Surg 37(9):2155–2161PubMedCrossRefGoogle Scholar
  43. 43.
    David DS, Sakai S, Brennan BL, Riggio RA, Cheigh J, Stenzel KH et al (1973) Hypercalcemia after renal transplantation. Long-term follow-up data. N Engl J Med 289(8):398–401PubMedCrossRefGoogle Scholar
  44. 44.
    Geis WP, Popovtzer MM, Corman JL, Halgrimson CG, Groth CG, Starzi TE (1973) The diagnosis and treatment of hyperparathyroidism after renal homotransplantation. Surgery, Gynecology and Obstetrics 137(6):997–1010PubMedCentralPubMedGoogle Scholar
  45. 45.
    Rostaing L, Moreau-Gaudry X, Baron E, Cisterne JM, Monrozies-Bernadet P, Durand D (1997) Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism. Clin Nephrol 47(4):248–255PubMedGoogle Scholar
  46. 46.
    Lee PP, Schiffmann L, Offermann G, Beige J (2004) Effects of parathyroidectomy on renal allograft survival. Kidney Blood Press Res 27(3):191–196PubMedCrossRefGoogle Scholar
  47. 47.
    Evenepoel P, Claes K, Kuypers DR, Debruyne F, Vanrenterghem Y (2007) Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrol Dial Transplant 22(6):1730–1737PubMedCrossRefGoogle Scholar
  48. 48.
    Evenepoel P, Claes K, Kuypers D, Maes B, Vanrenterghem Y (2005) Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transplant 20(8):1714–1720PubMedCrossRefGoogle Scholar
  49. 49.
    Massfelder T, Parekh N, Endlich K, Saussine C, Steinhausen M, Helwig JJ (1996) Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthetized rat. Br J Pharmacol 118(8):1995–2000PubMedCentralPubMedCrossRefGoogle Scholar
  50. 50.
    Ogata H, Ritz E, Odoni G, Amann K, Orth SR (2003) Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors. J Am Soc Nephrol 14(4):959–967PubMedCrossRefGoogle Scholar
  51. 51.
    Kerby JD, Rue LW, Blair H, Hudson S, Sellers MT, Diethelm AG (1998) Operative treatment of tertiary hyperparathyroidism: a single-center experience. Ann Surg 227(6):878–886PubMedCentralPubMedCrossRefGoogle Scholar
  52. 52.
    Schwarz A, Rustien G, Merkel S, Radermacher J, Haller H (2007) Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant 22(2):584–591PubMedCrossRefGoogle Scholar
  53. 53.
    Jeon HJ, Kim YJ, Kwon HY, Koo TY, Baek SH, Kim HJ et al (2012) Impact of parathyroidectomy on allograft outcomes in kidney transplantation. Transpl Int 25(12):1248–1256PubMedCrossRefGoogle Scholar
  54. 54.
    Schlosser K, Endres N, Celik I, Fendrich V, Rothmund M, Fernandez ED (2007) Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! World J Surg 31(10):1947–1953PubMedCrossRefGoogle Scholar
  55. 55.
    Ogg CS (1967) Total parathyroidectomy in treatment of secondary (renal) hyperparathyroidism. Br Med J 4(5575):331–334PubMedCentralPubMedCrossRefGoogle Scholar
  56. 56.
    Schlosser K, Veit JA, Witte S, Fernández ED, Victor N, Knaebel H-P et al (2007) Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial. Trials 8(1):22PubMedCentralPubMedCrossRefGoogle Scholar
  57. 57.
    Schneider R, Slater EP, Karakas E, Bartsch DK, Schlosser K (2012) Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg 36(2):318–326PubMedCrossRefGoogle Scholar
  58. 58.
    Lorenz K, Ukkat J, Sekulla C, Gimm O, Brauckhoff M, Dralle H (2006) Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol. World J Surg 30(5):743–751PubMedCrossRefGoogle Scholar
  59. 59.
    Pattou FN, Pellissier LC, Noël C, Wambergue F, Huglo DG, Proye CA (2000) Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism. World J Surg 24(11):1330–1334PubMedCrossRefGoogle Scholar
  60. 60.
    Schneider R, Waldmann J, Ramaswamy A, Fernandez ED, Bartsch DK, Schlosser K (2011) Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy. World J Surg 35(6):1260–1265PubMedCrossRefGoogle Scholar
  61. 61.
    Aly A, Douglas M (2003) Embryonic parathyroid rests occur commonly and have implications in the management of secondary hyperparathyroidism. ANZ J Surg 73(5):284–288PubMedCrossRefGoogle Scholar
  62. 62.
    Maxwell PH, Winearls CG (1997) Recurrence of autonomous hyperparathyroidism in dialysis patients. Nephrol Dial Transplant 12(10):2195–2200PubMedCrossRefGoogle Scholar
  63. 63.
    Gaz RD, Doubler PB, Wang C (1987) The management of 50 unusual hyperfunctioning parathyroid glands. Surgery 102(6):949–957PubMedGoogle Scholar
  64. 64.
    Ockert S, Willeke F, Richter A, Jonescheit J, Schnuelle P, van der Woude F et al (2002) Total parathyroidectomy without autotransplantation as a standard procedure in the treatment of secondary hyperparathyroidism. Langenbecks Arch Surg 11387(5–6):204–209CrossRefGoogle Scholar
  65. 65.
    Coulston JE, Egan R, Willis E, Morgan JD (2010) Total parathyroidectomy without autotransplantation for renal hyperparathyroidism. Br J Surg 97(11):1674–1679PubMedCrossRefGoogle Scholar
  66. 66.
    Galloway PA, El-Damanawi R, Bardsley V, Pritchard NR, Fry AC, Ojha SK et al (2015) Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal disease. Nephron 129(3):197–201PubMedCrossRefGoogle Scholar
  67. 67.
    Weenig RH, Sewell LD, Davis MDP, McCarthy JT, Pittelkow MR (2007) Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 56(4):569–579PubMedCrossRefGoogle Scholar
  68. 68.
    Girotto JA, Harmon JW, Ratner LE, Nicol TL, Wong L, Chen H (2001) Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism. Surgery 130(4):645–650, discussion 50–1 PubMedCrossRefGoogle Scholar
  69. 69.
    Duh Q, Lim RC, Clark OH (1991) Calciphylaxis in secondary hyperparathyroidism: diagnosis and parathyroidectomy. Arch Surg 126(10):1213–1219PubMedCrossRefGoogle Scholar
  70. 70.
    Kang AS, McCarthy JT, Rowland C, Farley DR, Van Heerden JA (2000) Is calciphylaxis best treated surgically or medically? Surgery 128(6):967–972PubMedCrossRefGoogle Scholar
  71. 71.
    Caccitolo JA, Farley DR, van Heerden JA, Grant CS, Thompson GB, Sterioff S (1997) The current role of parathyroid cryopreservation and autotransplantation in parathyroid surgery: an institutional experience. Surgery 122(6):1062–1067PubMedCrossRefGoogle Scholar
  72. 72.
    Saxe AW, Spiegel AM, Marx SJ, Brennan MF (1982) Deferred parathyroid autografts with cryopreserved tissue after reoperative parathyroid surgery. Arch Surg 117(5):538–543PubMedCrossRefGoogle Scholar
  73. 73.
    Feldman AL, Sharaf RN, Skarulis MC, Bartlett DL, Libutti SK, Weinstein LS et al (1999) Results of heterotopic parathyroid autotransplantation: a 13-year experience. Surgery 126(6):1042–1048PubMedCrossRefGoogle Scholar
  74. 74.
    Borot S, Lapierre V, Carnaille B, Goudet P, Penfornis A (2010) Results of cryopreserved parathyroid autografts: a retrospective multicenter study. Surgery 147(4):529–535PubMedCrossRefGoogle Scholar
  75. 75.
    Tominaga Y (2006) Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease. Ups J Med Sci 111(3):277–292PubMedCrossRefGoogle Scholar
  76. 76.
    Cohen MS, Dilley WG, Wells SA, Moley JF, Doherty GM, Sicard GA et al (2005) Long-term functionality of cryopreserved parathyroid autografts: a 13-year prospective analysis. Surgery 138(6):1033–1041PubMedCrossRefGoogle Scholar
  77. 77.
    Agarwal A, Waghray A, Gupta S, Sharma R, Milas M (2013) Cryopreservation of parathyroid tissue: an illustrated technique using the Cleveland clinic protocol. J Am Coll Surg 216(1):e1–e9PubMedCrossRefGoogle Scholar
  78. 78.
    Guerrero MA, Evans DB, Lee JE, Bao R, Bereket A, Gantela S et al (2008) Viability of cryopreserved parathyroid tissue: when is continued storage versus disposal indicated? World J Surg 32(5):836–839PubMedCrossRefGoogle Scholar
  79. 79.
    Yoo J, Young JEM (2012) Secondary hyperparathyroidism: surgical. In: Khan AA, Clark OH (eds) Handbook of parathyroid diseases, 1st edn. Springer, New York, pp 159–180CrossRefGoogle Scholar
  80. 80.
    Lokey J, Pattou F, Mondragon-Sanchez A, Minuto M, Mullineris B, Wambergue F et al (2000) Intraoperative decay profile of intact (1–84) parathyroid hormone in surgery for renal hyperparathyroidism—a consecutive series of 80 patients. Surgery 128(6):1029–1034PubMedCrossRefGoogle Scholar
  81. 81.
    Barczyński M, Cichoń S, Konturek A, Cichoń W (2005) A randomised study on a new cost-effective algorithm of quick intraoperative intact parathyroid hormone assay in secondary hyperparathyroidism. Langenbecks Arch Surg 390(2):121–127PubMedCrossRefGoogle Scholar
  82. 82.
    Seehofer D, Rayes N, Klupp J, Steinmüller T, Ulrich F, Müller C et al (2005) Predictive value of intact parathyroid hormone measurement during surgery for renal hyperparathyroidism. Langenbecks Arch Surg 390(3):222–229PubMedCrossRefGoogle Scholar
  83. 83.
    Weber T, Zeier M, Hinz U, Schilling T, Büchler MW (2005) Impact of intraoperative parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism. World J Surg 29(9):1176–1179PubMedCrossRefGoogle Scholar
  84. 84.
    Pitt SC, Panneerselvan R, Chen H, Sippel RS (2010) Secondary and tertiary hyperparathyroidism: the utility of ioPTH monitoring. World J Surg 34(6):1343–1349PubMedCentralPubMedCrossRefGoogle Scholar
  85. 85.
    Roshan A, Kamath B, Roberts S, Atkin S, England R (2006) Intra-operative parathyroid hormone monitoring in secondary hyperparathyroidism: is it useful? Clin Otolaryngol 31(3):198–203PubMedCrossRefGoogle Scholar
  86. 86.
    Moor JW, Roberts S, Atkin SL, England RJ (2011) Intraoperative parathyroid hormone monitoring to determine long-term success of total parathyroidectomy for secondary hyperparathyroidism. Head Neck 33(3):293–296PubMedGoogle Scholar
  87. 87.
    Muller-Stich BP, Brandle M, Binet I, Warschkow R, Lange J, Clerici T (2007) To autotransplant simultaneously or not–can intraoperative parathyroid hormone monitoring reliably predict early postoperative parathyroid hormone levels after total parathyroidectomy for hyperplasia? Surgery 142(1):47–56PubMedCrossRefGoogle Scholar
  88. 88.
    Freriks K, Hermus AR, de Sévaux RG, Bonenkamp HJ, Biert J, den Heijer M et al (2010) Usefulness of intraoperative parathyroid hormone measurements in patients with renal hyperparathyroidism. Head Neck 32(10):1328–1335PubMedCrossRefGoogle Scholar
  89. 89.
    Yamashita H, Cantor T, Uchino S, Watanabe S, Ogawa T, Moriyama T et al (2005) Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism. World J Surg 29(2):169–173PubMedCrossRefGoogle Scholar
  90. 90.
    Bieglmayer C, Kaczirek K, Prager G, Niederle B (2006) Parathyroid hormone monitoring during total parathyroidectomy for renal hyperparathyroidism: pilot study of the impact of renal function and assay specificity. Clin Chem 52(6):1112–1119PubMedCrossRefGoogle Scholar
  91. 91.
    Tominaga Y, Uchida K, Haba T, Katayama A, Sato T, Hibi Y et al (2001) More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 38(4):S168–S171PubMedCrossRefGoogle Scholar
  92. 92.
    Kestenbaum B, Andress DL, Schwartz SM, Gillen DL, Seliger SL, Jadav PR et al (2004) Survival following parathyroidectomy among United States dialysis patients. Kidney Int 66(5):2010–2016PubMedCrossRefGoogle Scholar
  93. 93.
    Conzo G, Perna AF, Savica V, Palazzo A, Pietra CD, Ingrosso D et al (2013) Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era. BMC Surg 13(Suppl 2):S4PubMedCentralPubMedCrossRefGoogle Scholar
  94. 94.
    Costa-Hong V, Jorgetti V, Gowdak LHW, Moyses RMA, Krieger EM, De Lima JJG (2007) Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery 142(5):699–703PubMedCrossRefGoogle Scholar
  95. 95.
    Cheng SP, Liu CL, Chen HH, Lee JJ, Liu TP, Yang TL (2009) Prolonged hospital stay after parathyroidectomy for secondary hyperparathyroidism. World J Surg 33(1):72–79PubMedCrossRefGoogle Scholar
  96. 96.
    Ureña P, Kubrusly M, Mannstadt M, Sarfati E, Drueke T (1994) Total or subtotal parathyroidectomy in uremic patients? Clin Nephrol 41(1):59–60PubMedGoogle Scholar
  97. 97.
    Sitges-Serra A, Caralps-Riera A (1987) Hyperparathyroidism associated with renal disease. Pathogenesis, natural history, and surgical treatment. Surg Clin North Am 67(2):359–377PubMedGoogle Scholar
  98. 98.
    Florescu MC, Islam KM, Plumb TJ, Smith-Shull S, Nieman J, Mandalapu P (2014) Calcium supplementation after parathyroidectomy in dialysis and renal transplant patients. Int J Nephrol Renovasc Dis 7:183–190PubMedCentralPubMedCrossRefGoogle Scholar
  99. 99.
    Latus J, Roesel M, Fritz P, Braun N, Ulmer C, Steurer W et al (2013) Incidence of and risk factors for hungry bone syndrome in 84 patients with secondary hyperparathyroidism. Int J Nephrol Renovasc Dis 6:131–137PubMedCentralPubMedCrossRefGoogle Scholar
  100. 100.
    Torer N, Torun D, Micozkadioglu H, Noyan T, Ozdemir FN, Haberal M (2009) Predictors of early postoperative hypocalcemia in hemodialysis patients with secondary hyperparathyroidism. In: Transplantation Proceedings. Elsevier, AmsterdamGoogle Scholar
  101. 101.
    Niramitmahapanya S, Sunthornthepvarakul T, Deerochanawong C, Sarinnapakorn V, Athipan P (2011) Role of loading calcitriol to control hypocalcemia after parathyroidectomy in chronic kidney disease. J Med Assoc Thai 94(3):295PubMedGoogle Scholar
  102. 102.
    Goh BL, Yudisthra MG, Hisham AN (2010) Alkaline phosphatase predicts calcium requirements after total parathyroidectomy in patients receiving dialysis. Br J Surg 97(2):185–188PubMedCrossRefGoogle Scholar
  103. 103.
    Kievit A, Tinnemans J, Idu M, Groothoff J, Surachno S, Aronson D (2010) Outcome of total parathyroidectomy and autotransplantation as treatment of secondary and tertiary hyperparathyroidism in children and adults. World J Surg 34(5):993–1000PubMedCentralPubMedCrossRefGoogle Scholar
  104. 104.
    Mozes MF, Soper WD, Jonasson O, Lang GR (1980) Total parathyroidectomy and autotransplantation in secondary hyperparathyroidism. Arch Surg 115(4):378–385PubMedCrossRefGoogle Scholar
  105. 105.
    Triponez F, Evenepoel P (2012) Pathophysiology and treatment of secondary and tertiary hyperparathyroidism. In: Oertli D, Udelsman R (eds) Surgery of the thyroid and parathyroid glands. Springer, Berlin Heidelberg, pp 517–536CrossRefGoogle Scholar
  106. 106.
    Dewberry LC, Tata S, Graves S, Weber CJ, Sharma J (2014) Predictors of tertiary hyperparathyroidism: Who will benefit from parathyroidectomy? Surgery 156(6):1631–1637PubMedCrossRefGoogle Scholar
  107. 107.
    Messa P, Cafforio C, Alfieri C (2011) Clinical impact of hypercalcemia in kidney transplant. International Journal of Nephrology 2011:906832PubMedCentralPubMedCrossRefGoogle Scholar
  108. 108.
    Jamal SA, Miller PD (2013) Secondary and tertiary hyperparathyroidism. J Clin Densitom 16(1):64–68PubMedCrossRefGoogle Scholar
  109. 109.
    Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y (2004) Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 19(5):1281–1287PubMedCrossRefGoogle Scholar
  110. 110.
    Kuo LE, Wachtel H, Karakousis G, Fraker D, Kelz R (2014) Parathyroidectomy in dialysis patients. J Surg Res 190(2):554–558PubMedCrossRefGoogle Scholar
  111. 111.
    Gupta PK, Smith RB, Gupta H, Forse RA, Fang X, Lydiatt WM (2012) Outcomes after thyroidectomy and parathyroidectomy. Head Neck 34(4):477–484PubMedCrossRefGoogle Scholar
  112. 112.
    Torregrosa JV, Barros X (2013) Management of hypercalcemia after renal transplantation. Nefrologia 33(6):751–757PubMedGoogle Scholar
  113. 113.
    Yamada S, Tokumoto M, Taniguchi M, Toyonaga J, Suehiro T, Eriguchi R, et al. (2015) Two years of cinacalcet hydrochloride treatment decreased parathyroid gland volume and serum parathyroid hormone level in hemodialysis patients with advanced secondary hyperparathyroidism. Therapeutic Apheresis and DialysisGoogle Scholar
  114. 114.
    Somnay YR, Weinlander E, Schneider DF, Sippel RS, Chen H (2014) The effect of cinacalcet on intraoperative findings in tertiary hyperparathyroidism patients undergoing parathyroidectomy. Surgery 156(6):1308–1314PubMedCentralPubMedCrossRefGoogle Scholar
  115. 115.
    Evenepoel P, Van Den Bergh B, Naesens M, De Jonge H, Bammens B, Claes K et al (2009) Calcium metabolism in the early posttransplantation period. Clin J Am Soc Nephrol 4(3):665–672PubMedCentralPubMedCrossRefGoogle Scholar
  116. 116.
    Triponez F, Clark OH, Vanrenthergem Y, Evenepoel P (2008) Surgical treatment of persistent hyperparathyroidism after renal transplantation. Ann Surg 248(1):18–30PubMedCrossRefGoogle Scholar
  117. 117.
    Tominaga Y, Numano M, Tanaka Y, Uchida K, Takagi H, editors. Surgical treatment of renal hyperparathyroidism. Seminars in Surgical Oncology; 1997: Wiley.Google Scholar
  118. 118.
    Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H (1997) Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13(2):78–86PubMedCrossRefGoogle Scholar
  119. 119.
    Fukagawa M, Kitaoka M, Yi H, Fukuda N, Matsumoto T, Ogata E et al (1994) Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 68(2):221–228PubMedCrossRefGoogle Scholar
  120. 120.
    Bonarek H, Merville P, Bonarek M, Moreau K, Morel D, Aparicio M et al (1999) Reduced parathyroid functional mass after successful kidney transplantation. Kidney Int 56(2):642–649PubMedCrossRefGoogle Scholar
  121. 121.
    Muirhead N, Zaltman J, Gill J, Churchill D, Poulin-Costello M, Mann V et al (2014) Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice. Clin Transplant 28(2):161–165PubMedCrossRefGoogle Scholar
  122. 122.
    Reinhardt W, Bartelworth H, Jockenhövel F, Schmidt-Gayk H, Witzke O, Wagner K et al (1998) Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 13(2):436–442PubMedCrossRefGoogle Scholar
  123. 123.
    Heaf J, Tvedegaard E, Kanstrup IL, Fogh-Andersen N (2000) Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 14(5):457–463PubMedCrossRefGoogle Scholar
  124. 124.
    Ozdemir F, Afsar B, Akgul A, Usluoğulları C, Akçay A, Haberal M (2006) Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients. Transplant Proc 38(2):480–482PubMedCrossRefGoogle Scholar
  125. 125.
    Messa P, Sindici C, Cannella G, Miotti V, Risaliti A, Gropuzzo M et al (1998) Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int 54(5):1704–1713PubMedCrossRefGoogle Scholar
  126. 126.
    Torres A, Lorenzo V, Salido E (2002) Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol 13(2):551–558PubMedGoogle Scholar
  127. 127.
    Shen WT, Kebebew E, Suh I, Duh QY, Clark OH (2009) Two hundred and two consecutive operations for secondary hyperparathyroidism: has medical management changed the profiles of patients requiring parathyroidectomy? Surgery 146(2):296–299PubMedCrossRefGoogle Scholar
  128. 128.
    Ferreira GF, Montenegro FLM, Machado DJ, Ianhez LE, Nahas WC, David-Neto E (2011) Parathyroidectomy after kidney transplantation: short-and long-term impact on renal function. Clinics (Sao Paulo) 66(3):431–435CrossRefGoogle Scholar
  129. 129.
    Park JH, Kang S-W, Jeong JJ, Nam K-H, Chang HS, Chung WY et al (2011) Surgical treatment of tertiary hyperparathyroidism after renal transplantation: a 31-year experience in a single institution. Endocr J 58(10):827–833PubMedCrossRefGoogle Scholar
  130. 130.
    Parikh S, Nagaraja H, Agarwal A, Samavedi S, Visger J, Nori U et al (2013) Impact of post-kidney transplant parathyroidectomy on allograft function. Clin Transplant 27(3):397–402PubMedCentralPubMedCrossRefGoogle Scholar
  131. 131.
    Pinheiro HS, Câmara NOS, Osaki KS, De Moura LAR, Pacheco-Silva A (2005) Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival. Am J Transplant 5(2):323–329PubMedCrossRefGoogle Scholar
  132. 132.
    Meola M, Petrucci I, Barsotti G (2009) Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism. Nephrol Dial Transplant 24(3):982–989PubMedCentralPubMedCrossRefGoogle Scholar
  133. 133.
    Komaba H, Nakanishi S, Fujimori A, Tanaka M, Shin J, Shibuya K et al (2010) Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism. Clin J Am Soc Nephrol 5(12):2305–2314PubMedCentralPubMedCrossRefGoogle Scholar
  134. 134.
    Yuan CM, Nee R, Narayan R, Abbott KC (2012) Treatment of secondary hyperparathyroidism with parathyroidectomy instead of cinacalcet: time to pick the low-hanging fruit? Am J Kidney Dis 60(2):179–181PubMedCrossRefGoogle Scholar
  135. 135.
    Kandil E, Florman S, Alabbas H, Abdullah O, McGee J, Noureldine S et al (2010) Exploring the effect of parathyroidectomy for tertiary hyperparathyroidism after kidney transplantation. Am J Med Sci 339(5):420–424PubMedCentralPubMedCrossRefGoogle Scholar
  136. 136.
    Copley JB, Wüthrich RP (2011) Therapeutic management of post-kidney transplant hyperparathyroidism. Clin Transplant 25(1):24–39PubMedCrossRefGoogle Scholar
  137. 137.
    Rayes N, Seehofer D, Schindler R et al (2008) Long-term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients. Arch Surg 143(8):756–761Google Scholar
  138. 138.
    Sadideen HM, Taylor JD, Goldsmith DJ (2012) Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up. Int Urol Nephrol 44(1):275–281Google Scholar
  139. 139.
    Drakopoulos S, Koukoulaki M, Apostolou T et al (2009) Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation. Am J Surg 198(2):178–183Google Scholar
  140. 140.
    Tseng PY, Yang WC, Yang CY et al (2015) Long-term Outcomes of Parathyroidectomy in Kidney Transplant Recipients with Persistent Hyperparathyroidism. Kidney Blood Press Res 40(4):386–394Google Scholar
  141. 141.
    Pitt SC, Panneerselvan R, Chen H et al (2009) Tertiary hyperparathyroidism: is less than a subtotal resection ever appropriate? A study of long-term outcomes. Surgery 146(6):1130–1137Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Kerstin Lorenz
    • 1
  • Detlef K. Bartsch
    • 2
  • Juan J. Sancho
    • 3
  • Sebastien Guigard
    • 4
  • Frederic Triponez
    • 5
  1. 1.Department of General-, Visceral-, and Vascular SurgeryMartin-Luther University of Halle-WittenbergHalle (Saale)Germany
  2. 2.Department of Visceral, Thoracic and Vascular SurgeryPhilipps University MarburgMarburgGermany
  3. 3.Department of General Surgery, Endocrine Surgery Unit, Hospital del MarUniversitat Autònoma de BarcelonaBarcelonaSpain
  4. 4.Department of Thoracic and Endocrine SurgeryUniversity Hospitals of Geneva, SwitzerlandGenevaSwitzerland
  5. 5.Chirurgie thoracique et endocrinienneHôpitaux Universitaires de GenèveGenevaSwitzerland

Personalised recommendations